Vascular access in hemodialysis: Issues, management, and emerging concepts

Cardiology Clinics

Volumn 23, Issue 3, 2005, Pages 249-273

  Roy Chaudhury, Prabir ^a   Kelly, Burnett S ^a   Melhem, Murad ^a   Zhang, Jianhua ^a   Li, Jinsong ^a   Desai, Pankaj ^a   Munda, Rino ^a   Heffelfinger, Sue C ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CILAZAPRIL; CLOPIDOGREL; CYCLIN DEPENDENT KINASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; POLITEF; RAPAMYCIN; RETINOBLASTOMA PROTEIN; ROSIGLITAZONE; SCATTER FACTOR; SILICONE; SIMVASTATIN; TRANSCRIPTION FACTOR E2F; TYRPHOSTIN; VERAPAMIL;

ADVENTITIA; ARTERIOVENOUS FISTULA; ARTERY DILATATION; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL WALL; BONE MARROW CELL; CATHETER; CLINICAL PROTOCOL; CLINICAL TRIAL; DEVICE INFECTION; DRUG DELIVERY SYSTEM; ENDOTHELIUM; GENE THERAPY; HEALTH SURVEY; HEART FAILURE; HEMODIALYSIS; HEMODYNAMICS; HUMAN; INFECTION; INFLAMMATION; INTIMA; MATURATION; MEDICAL CARE; MODEL; MORBIDITY; MORTALITY; NEEDLE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PHOTODYNAMIC THERAPY; POLITEF IMPLANT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; STANDARD; STENT; STRESS; SURGICAL TECHNIQUE; SYSTEMIC THERAPY; TISSUE REGENERATION; TREATMENT FAILURE; UREMIA; VASCULAR ACCESS; VEIN OCCLUSION; VEIN THROMBOSIS;

ARTERIOVENOUS ANASTOMOSIS; ARTERIOVENOUS SHUNT, SURGICAL; BLOOD VESSEL PROSTHESIS; CATHETERS, INDWELLING; CONSTRICTION, PATHOLOGIC; HUMANS; KIDNEY FAILURE, CHRONIC; PERIPHERAL VASCULAR DISEASES; POLYTETRAFLUOROETHYLENE; RENAL DIALYSIS;

EID: 23244432645     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.04.004     Document Type: Review

References (169)

1. US Renal Data System. USRDS 2002 Annual data report. 2002.
2. H.I. Feldman, S. Kobrin, and A. Wasserstein Hemodialysis vascular access morbidity J Am Soc Nephrol 7 1996 523 535
3. M.J. Brescia, J.E. Cimino, and K. Appel Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula N Engl J Med 275 1966 1089 1092
4. M.B. Silva Jr., R.W. Hobson II, and P.J. Pappas Vein transposition in the forearm for autogenous hemodialysis access J Vasc Surg 26 6 1997 981 986 [discussion: 7-8]
5. N. Gormus, U. Ozergin, and K. Durgut Comparison of autologous basilic vein transpositions between forearm and upper arm regions Ann Vasc Surg 17 5 2003 522 525
6. A. Taghizadeh, P. Dasgupta, and M.S. Khan Long-term outcomes of brachiobasilic transposition fistula for haemodialysis Eur J Vasc Endovasc Surg 26 6 2003 670 672
7. S.B. Palder, R.L. Kirkman, and A.D. Whittemore Vascular access for hemodialysis. Patency rates and results of revision Ann Surg 202 2 1985 235 239
8. M. Malovrh Native arteriovenous fistula: preoperative evaluation Am J Kidney Dis 39 6 2002 1218 1225
9. S.J. Schwab, J.T. Harrington, and A. Singh Vascular access for hemodialysis [clinical conference] Kidney Int 55 5 1999 2078 2090
10. F.J. Albers Causes of hemodialysis access failure Adv Ren Replace Ther 1 2 1994 107 118
11. L. Turmel-Rodrigues, J. Pengloan, and S. Baudin Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology Nephrol Dial Transplant 15 12 2000 2029 2036
12. S.J. Schwab, M.J. Oliver, and P. Suhocki Hemodialysis arteriovenous access: detection of stenosis and response to treatment by vascular access blood flow Kidney Int 59 1 2001 358 362
13. G.A. Beathard The treatment of vascular access dysfunction: a nephrologists view and experience Adv Ren Replace Ther 1 1994 131 147
14. P.J. Blankestijn, P.J. Bosman, and F.T. Boereboom Haemodialysis access without thrombosis: is it possible? [editorial] Nephrol Dial Transplant 11 12 1996 2394 2397
15. J. Himmelfarb, and T. Saad Hemodialysis vascular access: emerging concepts Curr Opin Nephrol Hypertens 5 6 1996 485 491
16. T.C. Hodges, M.F. Fillinger, and R.M. Zwolak Longitudinal comparison of dialysis access methods: risk factors for failure J Vasc Surg 26 6 1997 1009 1019
17. S.J. Schwab, M.A. Weiss, and F. Rushton Multicenter clinical trial results with the LifeSite hemodialysis access system Kidney Int 62 3 2002 1026 1033
18. K.B. Stevenson Management of hemodialysis vascular access infections R.J. Gray J.J. Sands Dialysis access: a multidisciplinary approach 2002 Lippincott Williams and Wilkins Philadelphia 98 106
19. K.B. Stevenson, E.L. Hannah, and C.A. Lowder Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access Am J Kidney Dis 39 3 2002 549 555
20. Dialysis Outcomes Quality Initiative III NKF-K/DOQI clinical practice guidelines for vascular access: update 2000 Am J Kidney Dis 37 1 Suppl 1 2001 S137 S181
21. H. Schanzer Overview of complications and management after vascular access creation R.J. Gray J.J. Sands Dialysis access: a multidisciplinary approach 2002 Lippincott, Williams and Wilkins Philadelphia 93 97
22. J.M. MacRae, S. Pandeya, and D.P. Humen Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms Am J Kidney Dis 43 5 2004 e17 e22
23. Y. Ori, A. Korzets, and M. Katz Hemodialysis arteriovenous access - a prospective hemodynamic evaluation Nephrol Dial Transplant 11 1996 94 97
24. Y. Iwashima, T. Horio, and Y. Takami Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF Am J Kidney Dis 40 5 2002 974 982
25. A.D. Timmis, R.J. McGonigle, and M.J. Weston The influence of hemodialysis fistulas on circulatory dynamics and left ventricular function Int J Artif Organs 5 2 1982 101 104
26. P. Unger, S. Velez-Roa, and K.M. Wissing Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up Am J Transplant 4 2004 2038
27. H.C. Rayner, A. Besarab, and W.W. Brown Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines Am J Kidney Dis 44 5 Suppl 3 2004 22 26
28. K.R. Polkinghorne, S.P. McDonald, and R.C. Atkins Vascular access and all-cause mortality: a propensity score analysis J Am Soc Nephrol 15 2 2004 477 486
29. S. Pastan, J.M. Soucie, and W.M. McClellan Vascular access and increased risk of death among hemodialysis patients Kidney Int 62 2 2002 620 626
30. R.K. Dhingra, E.W. Young, and T.E. Hulbert-Shearon Type of vascular access and mortality in US hemodialysis patients Kidney Int 60 4 2001 1443 1451
31. B.R. Di Iorio, V. Bellizzi, and N. Cillo Vascular access for hemodialysis: the impact on morbidity and mortality J Nephrol 17 1 2004 19 25
32. J. Himmelfarb, P. Stenvinkel, and T.A. Ikizler The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 5 2002 1524 1538
33. G.A. Kaysen The microinflammatory state in uremia: causes and potential consequences J Am Soc Nephrol 12 7 2001 1549 1557
34. G.A. Kaysen, and J.P. Eiserich Characteristics and effects of inflammation in end-stage renal disease Semin Dial 16 6 2003 438 446
35. J.D. Elson, G.J. Becker, and M.H. Wholey Vena caval and central venous stenoses: management with Palmaz balloon-expandable intraluminal stents J Vasc Interv Radiol 2 2 1991 215 223
36. A. Bornak, S. Wicky, and H.B. Ris Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions Eur Radiol 13 5 2003 950 956
37. O. Negulescu, M. Coco, and J. Croll Large atrial thrombus formation associated with tunneled cuffed hemodialysis catheters Clin Nephrol 59 1 2003 40 46
38. A. Shah, M. Murray, and C. Nzerue Right atrial thrombi complicating use of central venous catheters in hemodialysis Int J Artif Organs 27 9 2004 772 778
39. G.M. Nassar, and J.C. Ayus Infectious complications of the hemodialysis access Kidney Int 60 1 2001 1 13
40. M. Allon, D.B. Ornt, and S.J. Schwab Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group Kidney Int 58 5 2000 2178 2185
41. K.D. Gibson, M.T. Caps, and T.R. Kohler Assessment of a policy to reduce placement of prosthetic hemodialysis access Kidney Int 59 6 2001 2335 2345
42. K.L. Sullivan, A. Besarab, and J. Bonn Hemodynamics of failing dialysis grafts Radiology 186 3 1993 867 872
43. A. Besarab, K.L. Sullivan, and R.P. Ross Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis Kidney Int 47 5 1995 1364 1373
44. R.E. May, J. Himmelfarb, and M. Yenicesu Predictive measures of vascular access thrombosis: a prospective study Kidney Int 52 6 1997 1656 1662
45. M. Tonelli, D. Hirsch, and T.W. Clark Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty J Am Soc Nephrol 13 12 2002 2969 2973
46. M. Tonelli, K. Jindal, and D. Hirsch Screening for subclinical stenosis in native vessel arteriovenous fistulae J Am Soc Nephrol 12 8 2001 1729 1733
47. J.J. Sands, P.A. Jabyac, and C.L. Miranda Intervention based on monthly monitoring decreases hemodialysis access thrombosis ASAIO J 45 3 1999 147 150
48. S.J. Schwab, J.R. Raymond, and M. Saeed Prevention of hemodialysis fistula thrombosis. Early detection of venous stenoses Kidney Int 36 4 1989 707 711
49. P. McCarley, R.L. Wingard, and Y. Shyr Vascular access blood flow monitoring reduces access morbidity and costs Kidney Int 60 3 2001 1164 1172
50. S.J. Ram, J. Work, and G.C. Caldito A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts Kidney Int 64 1 2003 272 280
51. W.D. Paulson, S.J. Ram, and C.G. Birk Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis Am J Kidney Dis 35 6 2000 1089 1095
52. W.D. Paulson, S.J. Ram, and C.G. Birk Does blood flow accurately predict thrombosis or failure of hemodialysis synthetic grafts? A meta-analysis Am J Kidney Dis 34 3 1999 478 485
53. W.D. Paulson Blood flow surveillance of hemodialysis grafts and the dysfunction hypothesis Semin Dial 14 3 2001 175 180
54. J.S. Garland, L.M. Moist, and R.M. Lindsay Are hemodialysis access flow measurements by ultrasound dilution the standard of care for access surveillance? Adv Ren Replace Ther 9 2 2002 91 98
55. T.A. Depner, and N.M. Krivitski Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution ASAIO J 41 3 1995 M745 M749
56. K/DOQI NKF Clinical practice guidelines for vascular access 2000 Am J Kidney Dis 37 2001 S137 S181
57. S. Stracke, K. Konner, and I. Kostlin Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas Kidney Int 61 3 2002 1011 1019
58. M.F. Weiss, V. Scivittaro, and J.M. Anderson Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access Am J Kidney Dis 37 5 2001 970 980
59. C. Chen, D.N. Ku, and D. Kikeri Tenascin: a potential role in human arteriovenous PTFE graft failure J Surg Res 60 2 1996 409 416
60. M.D. Rekhter, and D. Gordon Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques Am J Pathol 147 3 1995 668 677
61. S.H. Swedberg, B.G. Brown, and R. Sigley Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment Circulation 80 6 1989 1726 1736
62. P. Roy-Chaudhury, B.S. Kelly, and M.A. Miller Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts Kidney Int 59 6 2001 2325 2334
63. W.M. Abbott, and C.J. Kwdek Aortofemoral bypass for atherosclerotic aortoiliac disease occlusive disease C.B. Ernst J.C. Stanley Current therapy in vascular surgery 1995 Mosby Year Book St Louis (MO) 355
64. R.L. Dalman, and L.M. Taylor Infrainguinal revascularization procedures J.M. Porter L.M. Taylor Basic data underlying clinical decision making in vascular surgery 1994 Quality Medical Publishing St Louis (MO) 141
65. G.A. Beathard Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access grafts Kidney Int 45 5 1994 1401 1406
66. G.A. Beathard Percutaneous angioplasty for the treatment of venous stenosis: a nephrologist's view Semin Dial 8 1995 166 170
67. R.Y. Kanterman, T.M. Vesely, and T.K. Pilgram Dialysis access grafts: anatomic location of venous stenosis and results of angioplasty [erratum appears in Radiology 1995;196(2):582] Radiology 195 1 1995 135 139
68. L. Turmel-Rodrigues, J. Pengloan, and D. Blanchier Insufficient dialysis shunts: improved long-term patency rates with close hemodynamic monitoring, repeated percutaneous balloon angioplasty, and stent placement Radiology 187 1 1993 273 278
69. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 9 1998 916 931
70. L.D. Adams, R.L. Geary, and B. McManus A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media Circ Res 87 7 2000 623 631
71. A. Gnasso, C. Irace, and C. Carallo In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis Stroke 28 5 1997 993 998
72. D.N. Ku, D.P. Giddens, and C.K. Zarins Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress Arteriosclerosis 5 3 1985 293 302
73. S.L. Meyerson, C.L. Skelly, and M.A. Curi The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft J Vasc Surg 34 1 2001 90 97
74. E.J. Mattsson, T.R. Kohler, and S.M. Vergel Increased blood flow induces regression of intimal hyperplasia Arterioscler Thromb Vasc Biol 17 10 1997 2245 2249
75. D. Mezzano, E.O. Pais, and E. Aranda Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia Kidney Int 60 2001 1844 1850
76. S.T. Morris, J.J. McMurray, and A. Spiers Impaired endothelial function in isolated human uremic resistance arteries Kidney Int 60 2001 1077 1082
77. C. He, V. Charoenkul, and T. Kahn Impact of the surgeon on the prevalence of arteriovenous fistulas ASAIO J 48 1 2002 39 40
78. M. Allon, and M.L. Robbin Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions Kidney Int 62 4 2002 1109 1124
79. A.M. O'Hare, R.A. Dudley, and D.M. Hynes Impact of surgeon and surgical center characteristics on choice of permanent vascular access Kidney Int 64 2 2003 681 689
80. H.D. Danenberg, I. Fishbein, and J. Gao Macrophage depletion by clodronate containing liposomes reduces neointimal formation after balloon injury in rats and rabbits Circulation 106 2002 599 605
81. F.G. Welt, E.R. Edelman, and D.I. Simon Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon injured arteries Arterioscler Thromb Vasc Biol 20 2000 2553 2558
82. L.V. Tsui, A. Camrud, and J. Mondesire p27-p16 fusion gene inhibits angioplasty-induced neointimal hyperplasia and coronary artery occlusion Circ Res 89 4 2001 323 328
83. J.G. McArthur, H. Qian, and D. Citron p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia Mol Ther 3 1 2001 8 13
84. M.W. Chang, E. Barr, and M.M. Lu Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty J Clin Invest 96 5 1995 2260 2268
85. N. Ohashi, A. Matsumori, and Y. Furukawa Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury Arterioscler Thromb Vasc Biol 20 12 2000 2521 2526
86. M.G. Sirois, M. Simons, and E.R. Edelman Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening Circulation 95 3 1997 669 676
87. V. Lindner, and M.A. Reidy Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor Proc Natl Acad Sci U S A 88 9 1991 3739 3743
88. J.E. Rectenwald, L.L. Moldawer, and T.S. Huber Direct evidence for cytokine involvement in neointimal hyperplasia Circulation 102 14 2000 1697 1702
89. M. Usui, K. Egashira, and K. Ohtani Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys FASEB J 16 2002 1833 1840
90. K. Egashira, Q. Zhao, and C. Kataoka Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys Circ Res 90 2002 1167 1172
91. A. Schober, D. Manka, and P. von Hundelshausen Deposition of platelet RANTES triggering monocyte recruitment requires P selectin and is involved in neointima formation after arterial injury Circulation 106 2002 1523 1529
92. J. Fukada, S. Schena, and I. Tack FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model Circ Res 87 1 2000 66 72
93. C.J. McKenna, S.E. Burke, and T.J. Opgenorth Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model Circulation 97 25 1998 2551 2556
94. Y. Zou, Y. Hu, and M. Mayr Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice Circ Res 86 4 2000 434 440
95. K. Wang, Z. Zhou, and X. Zhou Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model J Am Coll Cardiol 38 2 2001 577 582
96. K. Isoda, K. Nishikawa, and Y. Kamezawa Osteopontin plays an important role in the development of medial thickening and neointimal formation Circ Res 91 2002 77 82
97. B. Zhu, D.G. Kuhel, and D.O. Witte Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice Am J Pathol 157 2000 1839 1848
98. Y. Hu, A.H. Baker, and Y. Zou Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model Arterioscler Thromb Vasc Biol 21 8 2001 1275 1280
99. K. Hayashi, S. Nakamura, and R. Morishita In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model Gene Ther 7 19 2000 1664 1671
100. S. Humphries, C. Bauters, and A. Meirhaeghe The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis Eur Heart J 23 2002 692 694
101. C.S. Isbir, S. Akgun, and H. Yilmaz Is there a role of angiotensin-converting enzyme gene polymorphism in the failure of arteriovenous femoral shunts for hemodialysis? Ann Vasc Surg 15 4 2001 443 446
102. G. Keren Compensatory enlargement, remodeling, and restenosis Adv Exp Med Biol 430 1997 187 196
103. P. Libby, and H. Tanaka The molecular bases of restenosis Prog Cardiovasc Dis 40 2 1997 97 106
104. Y. Nakamura, H. Zhao, and C. Yutani Morphometric and histologic assessment of remodeling associated with restenosis after percutaneous transluminal coronary angioplasty Cardiology 90 2 1998 115 121
105. R.S. Schwartz, E.J. Topol, and P.W. Serruys Artery size, neointima, and remodeling: time for some standards J Am Coll Cardiol 32 7 1998 2087 2094
106. Y. Shi, J.E. O'Brien, and A. Fard Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries Circulation 94 7 1996 1655 1664
107. P. Roy-Chaudhury, L. McKee, and M. Miller Adventitial fibroblasts contribute to venous neointimal hyperplasia in PTFE dialysis grafts J Am Soc Nephrol 12 2001 301A
108. M. Sata, A. Saiura, and A. Kunisato Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis Nat Med 8 4 2002 403 409
109. M. Sata, Y. Hirata, and R. Nagai Circulating recipient cells contribute to graft coronary arteriolosclerosis J Cardiol 39 2002 48 49
110. A. Bayes-Genis, J.H. Campbell, and P.J. Carlson Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair Atherosclerosis 163 1 2002 89 98
111. K. Yokote, A. Take, and C. Nakaseko Bone marrow-derived vascular cells in response to injury J Atheroscler Thromb 10 4 2003 205 210
112. M.B. Leon, P.S. Teirstein, and J.W. Moses Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 4 2001 250 256
113. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 23 2002 1773 1780
114. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 3 2004 221 231
115. B.S. Kelly, S.C. Heffelfinger, and J.F. Whiting Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis Kidney Int 62 6 2002 2272 2280
116. T.R. Kohler, and T.R. Kirkman Dialysis access failure: a sheep model of rapid stenosis J Vasc Surg 30 4 1999 744 751
117. A.B. Lumsden, C. Chen, and K.A. Coyle Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models J Vasc Surg 24 5 1996 825 833
118. T. Ohno, D. Gordon, and H. San Gene therapy for vascular smooth muscle cell proliferation after arterial injury [see comments] Science 265 5173 1994 781 784
119. D. Brieger, and E. Topol Local drug delivery systems and prevention of restenosis Cardiovasc Res 35 1997 405 413
120. J.E. Sousa, M.A. Costa, and A. Abizaid Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 103 2 2001 192 195
121. J. Fingerle, R.M. Muller, and H. Kuhn Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries Arterioscler Thromb Vasc Biol 15 11 1995 1945 1950
122. K. Varty, K.E. Allen, and L. Jones Influence of losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein Br J Surg 81 6 1994 819 822
123. R.E. Law, W.P. Meehan, and X.P. Xi Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia J Clin Invest 98 8 1996 1897 1905
124. R.E. Law, S. Goetze, and X.P. Xi Expression and function of PPARgamma in rat and human vascular smooth muscle cells Circulation 101 11 2000 1311 1318
125. S. Goetze, X.P. Xi, and H. Kawano PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells J Cardiovasc Pharmacol 33 5 1999 798 806
126. P. Huang, W.J. Hawthorne, and A. Peng Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model Am J Surg 181 6 2001 492 498
127. S. Bellosta, F. Bernini, and N. Ferri Direct vascular effects of HMG-CoA reductase inhibitors Atherosclerosis 137 Suppl 1998 S101 S109
128. F. Dol, A. Mares, and J. Herbert Simvastatin inhibits myointimal hyperplasia following carotid artery injury in cholesterol-fed rabbits Blood Coagul Fibrinolysis 7 8 1996 772 778
129. M. Komukai, Y.S. Wajima, and J. Tashiro Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration Scand J Clin Lab Invest 59 3 1999 159 166
130. D.H. Walter, K. Rittig, and F.H. Bahlmann Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells Circulation 105 25 2002 3017 3024
131. C.R. Gregory, X. Huang, and R.E. Pratt Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement Transplantation 59 5 1995 655 661
132. R. Gallo, A. Padurean, and T. Jayaraman Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle Circulation 99 16 1999 2164 2170
133. R. Gradzki, R.K. Dhingra, and F.K. Port Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts Am J Kidney Dis 38 6 2001 1240 1244
134. Dialysis Access Consortium. 2002. Available at: http://www.niddk.nih.gov/ patient/DAC/DAC.htm. Accessed October 10, 2002.
135. M.R. Mayberg, Z. Luo, and S. London Radiation inhibition of intimal hyperplasia after arterial injury Radiat Res 142 2 1995 212 220
136. R. Waksman, K.A. Robinson, and I.R. Crocker Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention Circulation 91 5 1995 1533 1539
137. J.G. Wiedermann, C. Marboe, and H. Amols Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up J Am Coll Cardiol 25 6 1995 1451 1456
138. A.E. Raizner, S.N. Oesterle, and R. Waksman Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT) Circulation 102 9 2000 951 958
139. B.S. Kelly, A. Narayana, and S.C. Heffelfinger External beam radiation attenuates venous neointimal hyperplasia in a pig model of arteriovenous polytetrafluoroethylene (PTFE) graft stenosis Int J Radiat Oncol Biol Phys 54 1 2002 263 269
140. S. Parikh, D. Nori, and D. Rogers External beam radiation therapy to prevent postangioplasty dialysis access restenosis: a feasibility study Cardiovasc Radiat Med 1 1 1999 36 41
141. G.S. Cohen, H. Freeman, and M.A. Ringold External beam irradiation as an adjunctive treatment in failing dialysis shunts J Vasc Interv Radiol 11 3 2000 321 326
142. P. Roy-Chaudhury, D. Zuckerman, and H. Duncan Endovascular radiation therapy reduces venous stenosis in PTFE dialysis access grafts J Am Soc Nephrol 15 11 2004
143. H.S. Qian, K. Channon, and V. Neplioueva Improved adenoviral vector for vascular gene therapy: beneficial effects on vascular function and inflammation Circ Res 88 9 2001 911 917
144. H.E. von der Leyen, G.H. Gibbons, and R. Morishita Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene Proc Natl Acad Sci U S A 92 4 1995 1137 1141
145. L.L. Shears II, M.R. Kibbe, and A.D. Murdock Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo J Am Coll Surg 187 3 1998 295 306
146. M.W. Chang, E. Barr, and J. Seltzer Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science 267 5197 1995 518 522
147. M.J. Mann, A.D. Whittemore, and M.C. Donaldson Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 9189 1999 1493 1498
148. M. Degertekin, P.W. Serruys, and D.P. Foley Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up Circulation 106 13 2002 1610 1613
149. E.K. Hoffer, S. Sultan, and M.M. Herskowitz Prospective randomized trial of a metallic intravascular stent in hemodialysis graft maintenance J Vasc Interv Radiol 8 6 1997 965 973
150. G.A. Beathard Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts Kidney Int 43 4 1993 872 877
151. L.A. Turmel-Rodrigues, D. Blanchard, and J. Pengloan Wallstents and Craggstents in hemodialysis grafts and fistulas: results for selective indications J Vasc Interv Radiol 8 6 1997 975 982
152. R. Brauner, H. Laks, and D.C. Drinkwater Jr. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts J Thorac Cardiovasc Surg 114 1 1997 53 63
153. D. Teomim, I. Fishbien, and G. Golomb Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury J Control Release 60 1 1999 129 142
154. A.E. Villa, L.A. Guzman, and W. Chen Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty J Clin Invest 93 3 1994 1243 1249
155. A. Chaux, X.M. Ruan, and M.C. Fishbein Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation J Thorac Cardiovasc Surg 115 3 1998 604 612 [discussion: 12-4]
156. E.R. Edelman, M.A. Nugent, and M.J. Karnovsky Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition Proc Natl Acad Sci U S A 90 4 1993 1513 1517
157. S. Kaul, B. Cercek, and J. Rengstrom Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB J Am Coll Cardiol 35 2 2000 493 501
158. R.J. Laham, F.W. Sellke, and E.R. Edelman Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial Circulation 100 18 1999 1865 1871
159. J.J. Lopez, E.R. Edelman, and A. Stamler Local perivascular administration of basic fibroblast growth factor: drug delivery and toxicological evaluation [erratum appears in Drug Metab Dispos 1996;24(10):1166] Drug Metab Dispos 24 8 1996 922 924
160. G. Golomb, I. Fishbein, and S. Banai Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model Atherosclerosis 125 2 1996 171 182
161. B. Kelly, M. Melhem, and P. Desai Perivascular paclitaxel polymers reduce neointimal hyperplasia and venous stenosis in PTFE arteriovenous grafts: a solution for hemodialysis vascular access dysfunction? J Am Soc Nephrol 15 11 2004
162. A. Dardik, A. Liu, and B.J. Ballermann Chronic in vitro shear stress stimulates endothelial cell retention on prosthetic vascular grafts and reduces subsequent in vivo neointimal thickness J Vasc Surg 29 1 1999 157 167
163. G.L. Bowlin, and S.E. Rittgers Electrostatic endothelial cell transplantation within small-diameter (<6 mm) vascular prostheses: a prototype apparatus and procedure Cell Transplant 6 6 1997 631 637
164. G.L. Bowlin, and S.E. Rittgers Electrostatic endothelial cell seeding technique for small-diameter (<6 mm) vascular prostheses: feasibility testing Cell Transplant 6 6 1997 623 629
165. G.L. Bowlin, S.E. Rittgers, and A. Milsted In vitro evaluation of electrostatic endothelial cell transplantation onto 4 mm interior diameter expanded polytetrafluoroethylene grafts J Vasc Surg 27 3 1998 504 511
166. P.E. Szmitko, P.W. Fedak, and R.D. Weisel Endothelial progenitor cells: new hope for a broken heart Circulation 107 24 2003 3093 3100
167. T. Shirota, H. He, and H. Yasui Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing Tissue Eng 9 1 2003 127 136
168. G.M. LaMuraglia, J. Schiereck, and J. Heckenkamp Photodynamic therapy induces apoptosis in intimal hyperplastic arteries [in process citation] Am J Pathol 157 3 2000 867 875
169. D. Oda, A.M. Gown, and J.S. Vande Berg The fibroblast-like nature of myofibroblasts Exp Mol Pathol 49 3 1988 316 329